CV Sciences Shares Outstanding 2011-2019 | CVSI

CV Sciences shares outstanding from 2011 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CV Sciences Annual Shares Outstanding
(Millions of Shares)
2018 114
2017 80
2016 53
2015 35
2014 32
2013 10
2012 7
2011 7
2010 5
CV Sciences Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 99
Q2 2019 121
Q1 2019 95
Q4 2018 114
Q3 2018 116
Q2 2018 112
Q1 2018 96
Q4 2017 80
Q3 2017 88
Q2 2017 83
Q1 2017 60
Q4 2016 53
Q3 2016 52
Q2 2016 52
Q1 2016 50
Q4 2015 35
Q3 2015 35
Q2 2015 35
Q1 2015 34
Q4 2014 32
Q3 2014 33
Q2 2014 33
Q1 2014 26
Q4 2013 10
Q3 2013 10
Q2 2013 9
Q1 2013 8
Q4 2012 7
Q3 2012 7
Q2 2012 7
Q1 2012
Q4 2011 7
Q3 2011 7
Q2 2011 7
Q1 2011 7
Q4 2010
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.170B $0.048B
CV Sciences Inc. is a life science company. Its operating segment consists of specialty pharmaceuticals and consumer products. Specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol across several therapeutic areas. Consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products. It operates primarily in San Diego, California and Las Vegas, Nevada. CV Sciences Inc. is based in Las Vegas, United States.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $56.137B 33.58
Astellas Pharma (ALPMY) Japan $33.066B 15.76
Eisai (ESALY) Japan $19.882B 38.34
Merck (MKGAF) Germany $15.419B 21.04
Grifols, S.A (GRFS) Spain $14.796B 18.88
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.201B 481.61
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.999B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.026B 16.26
Sage Therapeutics (SAGE) United States $7.563B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.362B 9.40
Catalent (CTLT) United States $7.245B 29.48
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.320B 19.13
United Therapeutics (UTHR) United States $4.020B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.992B 91.52
FibroGen (FGEN) United States $3.617B 90.48
Nektar Therapeutics (NKTR) United States $3.513B 0.00
Evotec AG (EVTCY) Germany $3.183B 43.58
Taro Pharmaceutical Industries (TARO) Israel $2.962B 10.82
PTC Therapeutics (PTCT) United States $2.538B 0.00
Tilray (TLRY) Canada $2.287B 0.00
Portola Pharmaceuticals (PTLA) United States $2.214B 0.00
Zogenix (ZGNX) United States $1.920B 0.00
Xencor (XNCR) United States $1.887B 57.35
Pacira Pharmaceuticals (PCRX) United States $1.833B 54.35
Ironwood Pharmaceuticals (IRWD) United States $1.728B 55.10
Corcept Therapeutics (CORT) United States $1.715B 20.85
Heron Therapeutics (HRTX) United States $1.714B 0.00
USANA Health Sciences (USNA) United States $1.641B 17.51
Enanta Pharmaceuticals (ENTA) United States $1.250B 20.62
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.147B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.997B 0.00
Endo (ENDP) Ireland $0.982B 1.80
Spectrum Pharmaceuticals (SPPI) United States $0.973B 0.00
ArQule (ARQL) United States $0.925B 0.00
Karyopharm Therapeutics (KPTI) United States $0.924B 0.00
Aerie Pharmaceuticals (AERI) United States $0.891B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.817B 5.57
Dova Pharmaceuticals (DOVA) United States $0.806B 0.00
TherapeuticsMD (TXMD) United States $0.773B 0.00
Organogenesis Holdings (ORGO) United States $0.682B 0.00
Collegium Pharmaceutical (COLL) United States $0.669B 0.00
Flexion Therapeutics (FLXN) United States $0.627B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.563B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.522B 0.00
ImmunoGen (IMGN) United States $0.501B 0.00
Concordia (CXRXF) Canada $0.494B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Siga Technologies (SIGA) United States $0.450B 10.29
Dermira (DERM) United States $0.449B 0.00
OptiNose (OPTN) United States $0.414B 0.00
Recro Pharma (REPH) United States $0.391B 0.00
Indivior (INVVY) United States $0.387B 1.40
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.371B 16.03
Ardelyx (ARDX) United States $0.366B 0.00
DURECT (DRRX) United States $0.365B 0.00
Innate Pharma SA (IPHYF) France $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.19
Molecular Templates (MTEM) United States $0.338B 0.00
Harpoon Therapeutics (HARP) United States $0.320B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.297B 0.00
GlycoMimetics (GLYC) United States $0.271B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.265B 0.00
Rafael Holdings (RFL) United States $0.258B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.186B 0.00
Calithera Biosciences (CALA) United States $0.182B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 31.07
MARKER THERAPEUTICS, INC (MRKR) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Ocular Therapeutix (OCUL) United States $0.157B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.148B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Aquestive Therapeutics (AQST) United States $0.135B 0.00
Jounce Therapeutics (JNCE) United States $0.135B 1.80
MEI Pharma (MEIP) United States $0.135B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.35
Neos Therapeutics (NEOS) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Aclaris Therapeutics (ACRS) United States $0.081B 0.00
Generex Biotechnology (GNBT) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Lipocine (LPCN) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.064B 9.67
Adamis Pharmaceuticals (ADMP) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
IntelGenx Technologies (IGXT) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
AgeX Therapeutics (AGE) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
India Globalization Capital (IGC) United States $0.035B 0.00
Mast Therapeutics (SVRA) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Melinta Therapeutics (MLNT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
IsoRay (ISR) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00